Menu
Dividend AristocratsDividend KingsHigh YieldMonthly DividendDividend CalendarScreener

Johnson & Johnson Stock Price History

Johnson & Johnson EPS

EPSDividend / share
0.03.77.411.114.8200720102012201420172019202220242025

Johnson & Johnson Dividend per Share

Forward Yield
2.25%
Annual Dividend
5.24 USD
Payout
60.25%
Frequency
Quarterly
Yrs of growth
19
CAGR 5Y
5.25%
Status
Dividend Grower
0.01.42.84.25.619951998200120042007201020132016201920222025

Johnson & Johnson Dividend Yield

Johnson & Johnson Payout Ratio

0%191%381%572%763%200720102012201420172019202220242025

Johnson & Johnson Dividend Growth

1Y CAGR
3Y CAGR
5Y CAGR
10Y CAGR
20Y CAGR
4.68%
4.92%
5.25%
5.71%
7.22%
Compound annual growth rate of dividend per share
Yield vs sector
2.25%
avg Healthcare: 2.97%
Next ex-dividend (est.)
2026-08-25
last: 2026-05-26
Ex-DateAmount
2026-05-261.34 USD
2026-02-241.30 USD
2025-11-251.30 USD
2025-08-261.30 USD
2025-05-271.30 USD
2025-02-181.24 USD
2024-11-261.24 USD
2024-08-271.24 USD

Johnson & Johnson is a holding company engaged in the research, development, manufacture, and sale of healthcare products worldwide. It operates through two primary segments: Innovative Medicine, which focuses on pharmaceuticals including treatments for immunology, oncology, infectious diseases, neuroscience, cardiovascular and metabolic disorders, and pulmonary hypertension; and MedTech, which provides advanced surgical equipment, devices for orthopaedics, vision care, and solutions for robotics, navigation, and digital technologies. The company delivers innovative medicines and medical technologies that address unmet patient needs across diverse therapeutic areas, supporting healthcare professionals and consumers globally. Johnson & Johnson plays a pivotal role in the healthcare sector by advancing medical innovation and improving health outcomes through its broad portfolio of branded products and services. Founded in 1887 and headquartered in New Brunswick, New Jersey, it remains a cornerstone of the global health technology and pharmaceuticals industry.